Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCC1 ABCA2 ABCA12 ATP13A3 ABCC2 ABCG8	2.82e-06	49	163	6	GO:0140359
GeneOntologyMolecularFunction	profilin binding	DIAPH1 VASP HTT	1.44e-04	13	163	3	GO:0005522
GeneOntologyCellularComponent	axon	IMPA1 NRCAM MAP2 MYCBP2 HCN1 NTRK3 KIF21A SRI GRIK1 GRIN2A RET SYNJ2 PTPRS SCN10A SYN1 TRPV4 CNGB1 HTT	2.46e-04	891	165	18	GO:0030424
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	SEC16B ABCA2 ITCH SYN3 DSG1 ABCA12 SRI GRIN2A OCRL SNX21 RET ITGAX SNX13 PEF1 PTPRS BST1 DIAPH1 SYN1 ATP13A3 ATM STX10 CNGB1 HTT	2.52e-04	1307	165	23	GO:0030659
GeneOntologyCellularComponent	vesicle membrane	SEC16B ABCA2 ITCH SYN3 DSG1 ABCA12 SRI GRIN2A OCRL SNX21 RET ITGAX SNX13 PEF1 PTPRS BST1 DIAPH1 SYN1 ATP13A3 ATM STX10 CNGB1 HTT	3.06e-04	1325	165	23	GO:0012506
Domain	fn3	CHL1 COL7A1 NRCAM COL20A1 SPEG OBSCN IL20RB ITGB4 PTPRS	1.40e-05	162	165	9	PF00041
Domain	ABC_transporter_CS	ABCC1 ABCA2 ABCA12 ABCC2 ABCG8	3.31e-05	42	165	5	IPR017871
Domain	FN3	CHL1 COL7A1 NRCAM COL20A1 SPEG OBSCN IL20RB ITGB4 PTPRS	4.01e-05	185	165	9	SM00060
Domain	ABC_tran	ABCC1 ABCA2 ABCA12 ABCC2 ABCG8	6.38e-05	48	165	5	PF00005
Domain	ABC_TRANSPORTER_2	ABCC1 ABCA2 ABCA12 ABCC2 ABCG8	6.38e-05	48	165	5	PS50893
Domain	ABC_TRANSPORTER_1	ABCC1 ABCA2 ABCA12 ABCC2 ABCG8	7.05e-05	49	165	5	PS00211
Domain	FN3	CHL1 COL7A1 NRCAM COL20A1 SPEG OBSCN IL20RB ITGB4 PTPRS	7.07e-05	199	165	9	PS50853
Domain	ABC_transporter-like	ABCC1 ABCA2 ABCA12 ABCC2 ABCG8	7.78e-05	50	165	5	IPR003439
Domain	VWFA	COL7A1 COL20A1 PSMD4 ITGAX ITGB4 ITIH4	8.73e-05	82	165	6	PS50234
Domain	VWA	COL7A1 COL20A1 PSMD4 ITGAX ITGB4 ITIH4	9.99e-05	84	165	6	SM00327
Domain	FN3_dom	CHL1 COL7A1 NRCAM COL20A1 SPEG OBSCN IL20RB ITGB4 PTPRS	1.03e-04	209	165	9	IPR003961
Domain	-	ACACA SYN3 SYN1	1.81e-04	13	165	3	3.40.50.20
Domain	PreATP-grasp_dom	ACACA SYN3 SYN1	2.29e-04	14	165	3	IPR016185
Domain	Synapsin_pre-ATP-grasp_dom	SYN3 SYN1	2.31e-04	3	165	2	IPR020897
Domain	Synapsin_ATP-bd_dom	SYN3 SYN1	2.31e-04	3	165	2	IPR020898
Domain	SYNAPSIN_1	SYN3 SYN1	2.31e-04	3	165	2	PS00415
Domain	SYNAPSIN_2	SYN3 SYN1	2.31e-04	3	165	2	PS00416
Domain	Synapsin_C	SYN3 SYN1	2.31e-04	3	165	2	PF02750
Domain	Synapsin_N	SYN3 SYN1	2.31e-04	3	165	2	PF10581
Domain	Synapsin_CS	SYN3 SYN1	2.31e-04	3	165	2	IPR019735
Domain	Synapsin_P_site	SYN3 SYN1	2.31e-04	3	165	2	IPR019736
Domain	Synapsin	SYN3 SYN1	2.31e-04	3	165	2	PF02078
Domain	Synapsin	SYN3 SYN1	2.31e-04	3	165	2	IPR001359
Domain	VWF_A	COL7A1 COL20A1 PSMD4 ITGAX ITGB4 ITIH4	2.47e-04	99	165	6	IPR002035
Domain	-	ACACA SYN3 SYN1	2.85e-04	15	165	3	3.30.1490.20
Domain	PH_dom-like	RASA1 RAPH1 VEPH1 OBSCN RGS12 TYK2 PLEKHH2 VASP RASAL1 MAPK8IP2 AGAP1 SOS2	4.15e-04	426	165	12	IPR011993
Domain	Neurofascin/L1/NrCAM_C	CHL1 NRCAM	4.60e-04	4	165	2	IPR026966
Domain	Bravo_FIGEY	CHL1 NRCAM	4.60e-04	4	165	2	PF13882
Domain	Multidrug-R_assoc	ABCC1 ABCC2	4.60e-04	4	165	2	IPR005292
Domain	-	COL7A1 COL20A1 PSMD4 ITGB4 ITIH4	4.99e-04	74	165	5	3.40.50.410
Domain	ATP_grasp_subdomain_1	ACACA SYN3 SYN1	5.01e-04	18	165	3	IPR013815
Domain	-	ACACA SYN3 SYN1	5.01e-04	18	165	3	3.30.470.20
Domain	-	RASA1 RAPH1 VEPH1 OBSCN RGS12 PLEKHH2 VASP RASAL1 MAPK8IP2 AGAP1 SOS2	7.29e-04	391	165	11	2.30.29.30
Domain	PH	RASA1 RAPH1 VEPH1 OBSCN PLEKHH2 RASAL1 AGAP1 SOS2	9.98e-04	229	165	8	PF00169
Domain	VWA	COL7A1 COL20A1 ITGAX ITIH4	1.51e-03	56	165	4	PF00092
Domain	Ig_I-set	CHL1 MXRA5 NRCAM SPEG NTRK3 OBSCN PTPRS	1.52e-03	190	165	7	IPR013098
Domain	I-set	CHL1 MXRA5 NRCAM SPEG NTRK3 OBSCN PTPRS	1.52e-03	190	165	7	PF07679
Domain	APC_su10/DOC_dom	MYCBP2 HERC2	1.58e-03	7	165	2	IPR004939
Domain	DOC	MYCBP2 HERC2	1.58e-03	7	165	2	PS51284
Domain	ANAPC10	MYCBP2 HERC2	1.58e-03	7	165	2	PF03256
Domain	APC10	MYCBP2 HERC2	1.58e-03	7	165	2	SM01337
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ITCH ACACA RAPH1 MAP2 MYCBP2 EXPH5 ATG13 NTRK3 BAG3 DPP8 WNK1 RGS12 FAM83H RUSC2 USP31 MAST4 SYNJ2 USP54 FOXK1 ARHGAP19	7.82e-09	861	168	20	36931259
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ITCH ACACA RASA1 MAP2 MYCBP2 ATG13 TM9SF4 OBSCN GRIK1 POMT1 ME2 HNRNPC TYK2 YEATS2 PHKB CFAP20DC USF3 SYNJ2 PTPRS NUP210 CATSPERG ECHDC2 HTT AGAP1 FAM149A SOS2	1.42e-08	1489	168	26	28611215
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CBLL1 ITCH NRCAM MYCBP2 HCN1 KIF21A ADGRB3 GRIN2A UPF1 ITIH4 PPP2R1A WDR45 BCL11B PTPRS DIAPH1 FBXO41 SYN1 HERC2 RASAL1 MAPK8IP2	4.94e-08	963	168	20	28671696
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ZNF148 DYNC2H1 PSMD4 SOWAHC TYK2 YEATS2 LIG3 BCL11B DIAPH1 USP7 NCOA1 USP54 FOXK1	8.13e-08	398	168	13	35016035
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	USP34 VLDLR ABCA2 ITCH ZNF234 NRCAM MYCBP2 HCN1 KIF21A SRI ADGRB3 PSMD4 GRIK1 USP7 PPME1 ATM USP54 HERC2 MAPK8IP2 AGAP1 B4GALT3 SOS2	2.87e-07	1285	168	22	35914814
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 ABCA2 ACACA MYCBP2 SPEG TMEM158 OBSCN WNK1 ITGB4 FAM83H TYK2 GAREM2 PTPRS USP7 OGDHL PCNX1 HERC2 FOXK1 RASAL1 HTT	4.41e-07	1105	168	20	35748872
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	CBLL1 ABCC1 VLDLR UPF1 OCRL POMT1 RGS12 SNX13 FAM83H USP31 SYNJ2 PTCD2 ATP13A3 HERC2 ABCC2 TMEM68	4.73e-07	719	168	16	35337019
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	USP34 DNAJB11 MAP2 DYNC2H1 SRI ITGB4 RGS12 SLIT1 SCN10A SYN1 SMARCD1	5.37e-07	322	168	11	26514267
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	USP34 ITCH ZNF148 DYNC2H1 TM9SF4 BAG3 PSMD4 POMT1 LDAH MED24 PTPRS ATP13A3 ATM TMEM68 RNF145 STX10 GFM1 VASP PMM2	1.02e-06	1061	168	19	33845483
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	SYN3 NRCAM MAP2 MYCBP2 HCN1 ADGRB3 GRIN2A RUSC2 FBXO41 SYN1 HTT	1.12e-06	347	168	11	17114649
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 VLDLR DNAJB11 ITCH ZNF148 ABCA12 TPRN GPT SOWAHC ITIH4 FAM83H TYK2 YEATS2 BCL11B DIAPH1 USP7 SMARCD1 USP54 FOXK1	2.15e-06	1116	168	19	31753913
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ABCC1 DNAJB11 RAPH1 MYCBP2 TPRN DUSP1 BAG3 PSMD4 USP31 PPP1R8 PHKB PPP2R1A PTPRS NUP210 USP7 PPME1 HERC2 CDC25A	3.63e-06	1049	168	18	27880917
Pubmed	Regulator of G protein signaling 12 drives inflammatory arthritis by activating synovial fibroblasts through MYCBP2/KIF2A signaling.	MYCBP2 RGS12 HERC2	3.82e-06	7	168	3	36700049
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	CDKN1B ABCC1 GRIK1 RET BCL6 LIG3 ATM ABCC2 CDC25A ALOX12	8.85e-06	351	168	10	20453000
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DNAJB11 ITCH ACACA DSG1 MYCBP2 KIF21A BAG3 PSMD4 CHD1 UPF1 OCRL HNRNPC FAM83H LIG3 PPP2R1A DIAPH1 USP7 DDX43 HERC2 PMM2	9.36e-06	1353	168	20	29467282
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	SEC16B ZNF148 ZNF234 RAPH1 MYCBP2 MKRN2 BAG3 HNRNPC RRP1 CFAP20DC	1.13e-05	361	168	10	26167880
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	NRCAM WNK1 RUSC2 MAST4 SYNJ2 HERC2	1.19e-05	104	168	6	9205841
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ZNF148 ACACA RAPH1 DSG1 BAG3 PSMD4 CHD1 UPF1 OCRL WNK1 ME2 YEATS2 LIG3 PDLIM3 USP7 PPME1	1.32e-05	934	168	16	33916271
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP34 ATG13 KRT84 OBSCN ANKRD50 WNK1 UBOX5 ME2 ITGB4 MED24 PHKB SEPSECS TIA1 DIAPH1 OGDHL PCDH18 NPAT	2.18e-05	1084	168	17	11544199
Pubmed	RET signaling is required for survival and normal function of nonpeptidergic nociceptors.	RET SCN10A	2.32e-05	2	168	2	20237269
Pubmed	Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects.	ABCC1 ABCC2	2.32e-05	2	168	2	11266082
Pubmed	Postsynaptic TrkC and presynaptic PTPσ function as a bidirectional excitatory synaptic organizing complex.	NTRK3 PTPRS	2.32e-05	2	168	2	21262467
Pubmed	Characterization of the ATPase activity of human ATP-binding cassette transporter-2 (ABCA2).	ABCC1 ABCA2	2.32e-05	2	168	2	15999530
Pubmed	ATM kinase activity modulates ITCH E3-ubiquitin ligase activity.	ITCH ATM	2.32e-05	2	168	2	23435430
Pubmed	Abnormal axonal guidance and brain anatomy in mouse mutants for the cell recognition molecules close homolog of L1 and NgCAM-related cell adhesion molecule.	CHL1 NRCAM	2.32e-05	2	168	2	18588951
Pubmed	Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.	BCL11B ATM	2.32e-05	2	168	2	25486566
Pubmed	Orthologous relationship of obscurin and Unc-89: phylogeny of a novel family of tandem myosin light chain kinases.	SPEG OBSCN	2.32e-05	2	168	2	15185077
Pubmed	Cross-seeding fibrillation of Q/N-rich proteins offers new pathomechanism of polyglutamine diseases.	TIA1 HTT	2.32e-05	2	168	2	19386911
Pubmed	Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice.	USP34 ATM	2.32e-05	2	168	2	37043976
Pubmed	Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy.	USP7 HTT	2.32e-05	2	168	2	33170804
Pubmed	Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease.	BCL11B HTT	2.32e-05	2	168	2	18595722
Pubmed	Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia.	LIG3 ATM	2.32e-05	2	168	2	24342190
Pubmed	Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program.	ABCC1 ABCC2	2.32e-05	2	168	2	17606722
Pubmed	Deubiquitylation and stabilization of ARMC5 by ubiquitin-specific processing protease 7 (USP7) are critical for RCC proliferation.	ARMC5 USP7	2.32e-05	2	168	2	33544460
Pubmed	Clinical impact of ABCC1 and ABCC2 genotypes and haplotypes in mediating imatinib resistance among chronic myeloid leukaemia patients.	ABCC1 ABCC2	2.32e-05	2	168	2	25060527
Pubmed	Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia.	ATM NPAT	2.32e-05	2	168	2	8789452
Pubmed	Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease.	ATM HTT	2.32e-05	2	168	2	25540325
Pubmed	Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene.	ATM NPAT	2.32e-05	2	168	2	9199932
Pubmed	Interaction between CHL1 and serotonin receptor 2c regulates signal transduction and behavior in mice.	CHL1 HTR2C	2.32e-05	2	168	2	26527397
Pubmed	Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex.	ATM HTT	2.32e-05	2	168	2	28017939
Pubmed	Multidrug resistance-associated proteins are involved in the transport of the glutathione conjugates of the ultimate carcinogen of benzo[a]pyrene in human Caco-2 cells.	ABCC1 ABCC2	2.32e-05	2	168	2	22899102
Pubmed	Mutations of the Huntington's disease protein impact on the ATM-dependent signaling and repair pathways of the radiation-induced DNA double-strand breaks: corrective effect of statins and bisphosphonates.	ATM HTT	2.32e-05	2	168	2	24277524
Pubmed	Convergence of eicosanoid and integrin biology: 12-lipoxygenase seeks a partner.	ITGB4 ALOX12	2.32e-05	2	168	2	26037302
Pubmed	Metallothionein blocks oxidative DNA damage in vitro.	ABCC1 ABCC2	2.32e-05	2	168	2	22914987
Pubmed	Transporters MRP1 and MRP2 Regulate Opposing Inflammatory Signals To Control Transepithelial Neutrophil Migration during Streptococcus pneumoniae Lung Infection.	ABCC1 ABCC2	2.32e-05	2	168	2	29976647
Pubmed	HAUSP stabilizes Cdc25A and protects cervical cancer cells from DNA damage response.	USP7 CDC25A	2.32e-05	2	168	2	32860838
Pubmed	Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27.	CDKN1B BAG3	2.32e-05	2	168	2	16391524
Pubmed	Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.	NTRK3 RET	2.32e-05	2	168	2	33301751
Pubmed	Sorting nexin-21 is a scaffold for the endosomal recruitment of huntingtin.	SNX21 HTT	2.32e-05	2	168	2	30072438
Pubmed	Quantitative determination of the human MRP1 and MRP2 mRNA expression in FACS-sorted peripheral blood CD4+, CD8+, CD19+, and CD56+ cells.	ABCC1 ABCC2	2.32e-05	2	168	2	12890151
Pubmed	Primary cilia signaling mediates intraocular pressure sensation.	OCRL TRPV4	2.32e-05	2	168	2	25143588
Pubmed	p27Kip1 Is Required to Mediate a G1 Cell Cycle Arrest Downstream of ATM following Genotoxic Stress.	CDKN1B ATM	2.32e-05	2	168	2	27611996
Pubmed	p27(kip1) upregulated by hnRNPC1/2 antagonizes CagA (a virulence factor of Helicobacter pylori)-mediated pathogenesis.	CDKN1B HNRNPC	2.32e-05	2	168	2	22404445
Pubmed	AMP-activated protein kinase (AMPK) activity is not required for neuronal development but regulates axogenesis during metabolic stress.	ACACA MAP2 BCL11B	2.36e-05	12	168	3	21436046
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	CBLL1 ACACA PSMD4 CHD1 UPF1 WNK1 LMAN1L MED24 ARMC5 USP7 NCOA1 PPME1 SMARCD1 ATP13A3 TMEM68 CDC25A ALOX12 FOXK1 HTT	2.46e-05	1327	168	19	32694731
Pubmed	FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ.	CHD1 YEATS2 LIG3 PPP2R1A NCOA1 SMARCD1 HERC2	3.22e-05	183	168	7	36129980
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	HCN1 ADGRB3 GRIN2A ITIH4 DIAPH1 FBXO41 SYN1 RASAL1	3.24e-05	251	168	8	27507650
Pubmed	Genetic susceptibility to distinct bladder cancer subphenotypes.	CDKN1B RET BCL6 LIG3 ATM ABCC2 CDC25A ALOX12 ABCG8 NPAT	4.18e-05	421	168	10	19692168
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	RAPH1 MKRN2 UPF1 OCRL SNX21 ANKRD50 SOWAHC WNK1 HNRNPC RUSC2 CRY1 WDR45 SEPSECS VASP FOXK1 AGAP1	4.72e-05	1038	168	16	26673895
Pubmed	Loss of G9a does not phenocopy the requirement for Prdm12 in the development of the nociceptive neuron lineage.	NTRK3 RET SCN10A	4.83e-05	15	168	3	38167468
Pubmed	Foxg1 coordinates the switch from nonradially to radially migrating glutamatergic subtypes in the neocortex through spatiotemporal repression.	EBF2 BCL11B DMRT3	4.83e-05	15	168	3	23523356
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	RET WNK1 HNRNPC TMEM132C USF3 SCN10A USP7 ATM VASP SOS2	4.99e-05	430	168	10	35044719
Pubmed	14-3-3 proteins sequester a pool of soluble TRIM32 ubiquitin ligase to repress autoubiquitylation and cytoplasmic body formation.	MYCBP2 SPEG UPF1 WNK1	5.10e-05	42	168	4	23444366
Pubmed	Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes.	ABCA2 MXRA5 WNK1 PDLIM3 HERC2	5.62e-05	84	168	5	15203218
Pubmed	Heterogeneous nuclear ribonucleoprotein A3 controls mitotic progression of neural progenitors via interaction with cohesin.	BCL11B SYN1 ATM	5.92e-05	16	168	3	32321712
Pubmed	Receptor protein tyrosine phosphatases are expressed by cycling retinal progenitor cells and involved in neuronal development of mouse retina.	CDKN1B MAP2 PTPRS	5.92e-05	16	168	3	18308476
Pubmed	Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors.	CHL1 NRCAM BCL6 SLIT1	6.71e-05	45	168	4	22696295
Pubmed	Contribution of child ABC-transporter genetics to prenatal MeHg exposure and neurodevelopment.	ABCC1 ABCC2	6.94e-05	3	168	2	35654246
Pubmed	Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes.	ABCC1 ABCC2	6.94e-05	3	168	2	17890284
Pubmed	The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis.	ABCC1 ABCC2	6.94e-05	3	168	2	12628490
Pubmed	HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy.	BAG3 HTT	6.94e-05	3	168	2	18006506
Pubmed	Increased multidrug resistance-associated protein activity in mononuclear cells of patients with systemic lupus erythematosus.	ABCC1 ABCC2	6.94e-05	3	168	2	18799096
Pubmed	Different presynaptic roles of synapsins at excitatory and inhibitory synapses.	SYN3 SYN1	6.94e-05	3	168	2	15601943
Pubmed	Synapsin Isoforms Regulating GABA Release from Hippocampal Interneurons.	SYN3 SYN1	6.94e-05	3	168	2	27335405
Pubmed	WIP1 dephosphorylation of p27Kip1 Serine 140 destabilizes p27Kip1 and reverses anti-proliferative effects of ATM phosphorylation.	CDKN1B ATM	6.94e-05	3	168	2	31959038
Pubmed	The Lack of Synapsin Alters Presynaptic Plasticity at Hippocampal Mossy Fibers in Male Mice.	SYN3 SYN1	6.94e-05	3	168	2	38866497
Pubmed	Expression and localization of ATP binding cassette (ABC) family of drug transporters in gastric hepatoid adenocarcinomas.	ABCC1 ABCC2	6.94e-05	3	168	2	18439156
Pubmed	The proline-rich focal adhesion and microfilament protein VASP is a ligand for profilins.	DIAPH1 VASP	6.94e-05	3	168	2	7737110
Pubmed	Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.	DYNC2H1 SRI	6.94e-05	3	168	2	16320026
Pubmed	A family of drug transporters: the multidrug resistance-associated proteins.	ABCC1 ABCC2	6.94e-05	3	168	2	10944550
Pubmed	Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.	ABCC1 ABCC2	6.94e-05	3	168	2	25425682
Pubmed	Synapsin selectively controls the mobility of resting pool vesicles at hippocampal terminals.	SYN3 SYN1	6.94e-05	3	168	2	22442064
Pubmed	High-resolution structural analysis of mammalian profilin 2a complex formation with two physiological ligands: the formin homology 1 domain of mDia1 and the proline-rich domain of VASP.	DIAPH1 VASP	6.94e-05	3	168	2	18001770
Pubmed	Dual innervation of neonatal Merkel cells in mouse touch domes.	NTRK3 RET	6.94e-05	3	168	2	24637732
Pubmed	Ubiquitin ligase ITCH recruitment suppresses the aggregation and cellular toxicity of cytoplasmic misfolded proteins.	ITCH HTT	6.94e-05	3	168	2	24865853
Pubmed	Maternal synapsin autoantibodies are associated with neurodevelopmental delay.	SYN3 SYN1	6.94e-05	3	168	2	36742338
Pubmed	Lamellipodin promotes actin assembly by clustering Ena/VASP proteins and tethering them to actin filaments.	RAPH1 VASP	6.94e-05	3	168	2	26295568
Pubmed	Synapsins contribute to the dynamic spatial organization of synaptic vesicles in an activity-dependent manner.	SYN3 SYN1	6.94e-05	3	168	2	22933803
Pubmed	Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.	CDKN1B RET	6.94e-05	3	168	2	18316595
Pubmed	The Knockout of Synapsin II in Mice Impairs Social Behavior and Functional Connectivity Generating an ASD-like Phenotype.	SYN3 SYN1	6.94e-05	3	168	2	28922833
Pubmed	Synaptic and extrasynaptic origin of the excitation/inhibition imbalance in the hippocampus of synapsin I/II/III knockout mice.	SYN3 SYN1	6.94e-05	3	168	2	22368083
Pubmed	A role for VASP in RhoA-Diaphanous signalling to actin dynamics and SRF activity.	DIAPH1 VASP	6.94e-05	3	168	2	12805219
Pubmed	Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool.	SYN3 SYN1	6.94e-05	3	168	2	16554471
Pubmed	Synapsin IIa controls the reserve pool of glutamatergic synaptic vesicles.	SYN3 SYN1	6.94e-05	3	168	2	18945891
Pubmed	Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury.	ABCC1 ABCC2	6.94e-05	3	168	2	23896815
Pubmed	Compensatory network alterations upon onset of epilepsy in synapsin triple knock-out mice.	SYN3 SYN1	6.94e-05	3	168	2	21621590
Pubmed	ERK activation in axonal varicosities modulates presynaptic plasticity in the CA3 region of the hippocampus through synapsin I.	SYN3 SYN1	6.94e-05	3	168	2	19487674
Pubmed	Autism-related behavioral abnormalities in synapsin knockout mice.	SYN3 SYN1	6.94e-05	3	168	2	23280234
Pubmed	Cortico-hippocampal hyperexcitability in synapsin I/II/III knockout mice: age-dependency and response to the antiepileptic drug levetiracetam.	SYN3 SYN1	6.94e-05	3	168	2	20804820
Pubmed	Synapsins differentially control dopamine and serotonin release.	SYN3 SYN1	6.94e-05	3	168	2	20660258
Interaction	YWHAQ interactions	CBLL1 CDKN1B ITCH ACACA MAP2 MYCBP2 EXPH5 SPEG BAG3 UPF1 WNK1 ITGB4 HNRNPC RGS12 FAM83H RUSC2 CRY1 USP31 MAST4 SYNJ2 NCOA1 USP54 CDC25A VASP FOXK1 HTT AGAP1 ARHGAP19	9.97e-08	1118	164	28	int:YWHAQ
Interaction	YWHAB interactions	CDKN1B MAP2 MYCBP2 EXPH5 ATG13 SPEG BAG3 DPP8 WNK1 ITGB4 RGS12 FAM83H RUSC2 CRY1 USP31 PPP2R1A MAST4 SYNJ2 USP54 CDC25A FOXK1 HTT AGAP1 ARHGAP19	2.47e-06	1014	164	24	int:YWHAB
Interaction	SFN interactions	ITCH MAP2 MYCBP2 EXPH5 ATG13 NTRK3 DPP8 WNK1 RGS12 FAM83H RUSC2 USP31 MAST4 SYNJ2 USP7 USP54 CDC25A HTT ARHGAP19	3.77e-06	692	164	19	int:SFN
Interaction	PTPRA interactions	CHL1 ACACA RAPH1 MKRN2 PSMD4 RET TYK2 PPP2R1A PTPRS	8.10e-06	164	164	9	int:PTPRA
Interaction	YWHAZ interactions	CDKN1B RAPH1 MAP2 MYCBP2 EXPH5 ATG13 SPEG BAG3 DPP8 WNK1 RGS12 FAM83H RUSC2 CRY1 USP31 PPP2R1A MAST4 AK5 SYN1 ATM USP54 HERC2 CDC25A FOXK1 HTT AGAP1 ARHGAP19	8.20e-06	1319	164	27	int:YWHAZ
Interaction	UBE2L3 interactions	CDKN1B USP34 ITCH MYCBP2 MKRN2 BAG3 UBOX5 ZC3H6 NCOA1 HERC2	9.24e-06	211	164	10	int:UBE2L3
Interaction	YWHAH interactions	CDKN1B ABCA2 MAP2 MYCBP2 EXPH5 ATG13 SPEG BAG3 DPP8 WNK1 RGS12 FAM83H RUSC2 CRY1 USP31 MAST4 SYNJ2 NCOA1 USP54 CDC25A FOXK1 HTT AGAP1 ARHGAP19	1.01e-05	1102	164	24	int:YWHAH
Interaction	GRB2 interactions	CDKN1B DNAJB11 ITCH RASA1 MAP2 NTRK3 BAG3 OCRL RET ITGB4 HNRNPC ITIH4 GAREM2 SYNJ2 DIAPH1 SYN1 VASP HTT SOS2	3.19e-05	806	164	19	int:GRB2
GeneFamily	Fibronectin type III domain containing	CHL1 COL7A1 NRCAM COL20A1 OBSCN IL20RB ITGB4 PTPRS	1.22e-05	160	121	8	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CHL1 MXRA5 NRCAM SPEG NTRK3 OBSCN PTPRS	1.05e-04	161	121	7	593
GeneFamily	Synapsins	SYN3 SYN1	1.33e-04	3	121	2	1325
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RASA1 RAPH1 VEPH1 PLEKHH2 RASAL1 AGAP1 SOS2	4.75e-04	206	121	7	682
GeneFamily	Ubiquitin specific peptidases	USP34 USP31 USP7 USP54	5.36e-04	56	121	4	366
GeneFamily	Phosphoinositide phosphatases	IMPA1 OCRL SYNJ2	1.26e-03	32	121	3	1079
GeneFamily	Cyclic nucleotide gated channels	HCN1 CNGB1	1.93e-03	10	121	2	250
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA1 RASAL1	1.93e-03	10	121	2	830
GeneFamily	ATP binding cassette subfamily C	ABCC1 ABCC2	3.30e-03	13	121	2	807
GeneFamily	5-hydroxytryptamine receptors, G protein-coupled	HTR2C HTR4	3.30e-03	13	121	2	170
GeneFamily	ATP binding cassette subfamily A	ABCA2 ABCA12	3.84e-03	14	121	2	805
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	CDKN1B USP34 ABCC1 VLDLR ITCH ZNF148 RASA1 MYCBP2 DUSP1 CHD1 ME2 SNX13 CRY1 TIA1 SYNJ2 USP7 NCOA1 ATP13A3 AGAP1 ARHGAP19 PMM2 NPAT SOS2	4.81e-09	856	165	23	M4500
Coexpression	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	USP34 ABCC1 MYCBP2 USF3 PTPRS AK5 USP7 ATM ABCC2	3.31e-06	189	165	9	M3112
Coexpression	JAEGER_METASTASIS_DN	COL7A1 NRCAM DSG1 ABCA12 EXPH5 SOWAHC ITGB4 BCL11B MAST4 ECHDC2	6.30e-06	260	165	10	M10702
Coexpression	GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP	BAG3 UPF1 BCL11B SYNJ2 AK5 ATM ECHDC2 NPAT	3.84e-05	198	165	8	M3108
Coexpression	GSE1460_DP_VS_CD4_THYMOCYTE_UP	MKRN2 PSMD4 UPF1 ITIH4 WDR45 PEF1 HERC2 ARHGAP19	4.12e-05	200	165	8	M3452
Coexpression	GSE17721_LPS_VS_POLYIC_12H_BMDC_UP	USP34 TM9SF4 ITGAX CRY1 RRN3 PTCD2 PCNX1 CDC25A	4.12e-05	200	165	8	M3814
Coexpression	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	CHL1 MAP2 DUSP1 ITGB4 USP31 PDLIM3 AK5 PLEKHH2	5.08e-05	206	165	8	M14134
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	CHL1 VLDLR HTR4 NRCAM MAP2 MYCBP2 TM9SF4 KIF21A ADGRB3 RET BCL6 ZC3H6 SNX13 TMEM132C USP31 BCL11B USP7 ATP13A3 HERC2 PCDH18	3.67e-06	818	160	20	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	CHL1 NRCAM RASA1 MYCBP2 HCN1 TM9SF4 TMEM158 ADGRB3 CHD1 RET WNK1 TMEM132C USP31 LIG3 BCL11B PTPRS USP7 ATP13A3 HERC2	1.35e-05	818	160	19	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	ACACA MYCBP2 TM9SF4 SPEG TMEM158 ZC3H6 LDAH USP31 LIG3 AK5 ATP13A3	2.57e-05	312	160	11	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	VLDLR ITCH ZNF148 NTRK3 VEPH1 ADGRB3 GRIK1 OCRL TMEM132C PPP2R1A MAST4 PDLIM3 TIA1 DTX4 USP7 RNF145 HTT AGAP1	3.45e-05	799	160	18	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	RASA1 MYCBP2 TM9SF4 TMEM158 CHD1 WNK1 USP31 LIG3 PTPRS USP7 ATP13A3 HERC2	3.69e-05	385	160	12	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_500_k-means-cluster#1	MAP2 TMEM158 AK5 PCDH18 MAPK8IP2	8.23e-05	59	160	5	ratio_SC_vs_MESO_500_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	MYCBP2 TM9SF4 TMEM158 CHD1 ZC3H6 LDAH SNX13 USP31 LIG3 ATP13A3 HERC2	1.16e-04	369	160	11	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	CHL1 HTR4 MYCBP2 TM9SF4 TMEM158 CHD1 BCL6 ZC3H6 LDAH SNX13 TMEM132C USP31 LIG3 PDLIM3 ATP13A3 HERC2 PCDH18	1.28e-04	806	160	17	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
ToppCell	facs-Skin-Telogen-3m-Epithelial-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 ABCC1 ABCA12 EXPH5 GPT BCL6 SOWAHC RGS12 BCL11B	3.39e-08	183	168	9	26b18d1cc5d98f185176e100bafb9bc9081c66f7
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTR4 SYN3 EXPH5 NTRK3 CA10 NWD2 SYNJ2 CNGB1	4.91e-07	183	168	8	1645d4a55cd8c22d6eb47fc5c6b1e576c454f111
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTR4 SYN3 EXPH5 NTRK3 CA10 NWD2 SYNJ2 CNGB1	5.11e-07	184	168	8	34e316ad8e7b8667cd8ad61397281802a252744f
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 CDKN1B EXPH5 KIF21A IL20RB BCL6 ITGB4 BCL11B	6.78e-07	191	168	8	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SPEG NTRK3 ADGRB3 GRIN2A BCL6 EBF2 PDLIM3 MOCS1	8.56e-07	197	168	8	cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c
ToppCell	Tracheal\|World / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 KIF21A ADGRB3 ITGB4 SYNJ2 PTPRS TRPV4 RASAL1	9.59e-07	200	168	8	682960e28542a3d6c119047cd0131941932cfdea
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ABCC1 UPF1 LIG3 USF3 MAST4 PCNX1 PDZD4	4.66e-06	175	168	7	f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYN3 MAP2 HCN1 KIF21A RET C1orf232 CNGB1	4.84e-06	176	168	7	116741fef5895ca85057d2d31eca9eba5764ab44
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYN3 MAP2 HCN1 KIF21A RET C1orf232 CNGB1	4.84e-06	176	168	7	5b707f58d164ee7a6a527dd5d053472ce9a631c1
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EXPH5 CA10 NWD2 SYNJ2 AK5 SLIT1 RASAL1	5.02e-06	177	168	7	f30d757ee8db7e10d547498dab6560473c6ed7c0
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACACA VEPH1 MAST4 USP54 RNF145 AGAP1 FAM149A	5.21e-06	178	168	7	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHL1 SYN3 EXPH5 NTRK3 GRIK1 CA10 NWD2	5.81e-06	181	168	7	57994ff4ecffb15653aee00644d9f887f5e3461d
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYN3 EXPH5 CA10 NWD2 SYNJ2 AK5 SLIT1	6.25e-06	183	168	7	01ad18f198195ce341bae01a1c8c253cc4607766
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACACA VEPH1 MAST4 USP54 RNF145 AGAP1 FAM149A	6.47e-06	184	168	7	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	ACACA VEPH1 MAST4 USP54 RNF145 AGAP1 FAM149A	6.71e-06	185	168	7	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ACACA VEPH1 MAST4 USP54 RNF145 AGAP1 FAM149A	6.71e-06	185	168	7	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 SYN3 NRCAM MAP2 KIF21A RET CNGB1	6.71e-06	185	168	7	94d0f283d63d932f310cc5a17ea893d71ba60f5e
ToppCell	wk_15-18-Epithelial-PNS-MFNG+_DBH+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CHL1 HCN1 KIF21A RET OGDHL CNGB1 MAPK8IP2	6.95e-06	186	168	7	72f7427d62d65e37bb0bf99229a1b75df081a128
ToppCell	Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|World / Lineage, Cell type, age group and donor	ACACA VEPH1 MAST4 USP54 RNF145 AGAP1 FAM149A	7.20e-06	187	168	7	81cc8435b2704a9a8287b3f54acaae0f11dd4ac7
ToppCell	facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 EXPH5 GPT ITGB4 FAM83H DMRT3 TRPV4	7.20e-06	187	168	7	fe9fc21192ede2eea61f419d20ccda254569d0a6
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 MAP2 COL20A1 KIF21A ADGRB3 RET CNGB1	7.45e-06	188	168	7	9fd262bbf6cdebfd945e39428a6059726fb55b3a
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 NRCAM KIF21A RET NWD2 SLIT1 MAPK8IP2	7.45e-06	188	168	7	bd091503f580dedab40e0996273101285d24b586
ToppCell	5'-GW_trimst-2-LargeIntestine-Neuronal-neuron_precursor-Neuroblast\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 MAP2 COL20A1 KIF21A ADGRB3 RET CNGB1	7.45e-06	188	168	7	459e3fd4335a6f25f982d011b38702f4fcfed1cd
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 SPEG NTRK3 ITIH4 TMEM132C PDLIM3 PTPRS	7.71e-06	189	168	7	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	Globus_pallidus-Neuronal\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	HTR2C MYCBP2 GRIN2A FBXO41 SYN1 MAPK8IP2 PDZD4	7.98e-06	190	168	7	416de85d8841dac883faa6f5339b2fb461a09e82
ToppCell	tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs\|Myeloid_cells / Location, Cell class and cell subclass	CHL1 NRCAM KIF21A GPT GAREM2 VASP RASAL1	7.98e-06	190	168	7	58a6ab70737d719ca9725ac087f20dfe9be0463e
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPEG ITIH4 TMEM132C NWD2 PDLIM3 PTPRS PLEKHH2	8.26e-06	191	168	7	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs\|Myeloid_cells / Location, Cell class and cell subclass	CHL1 NRCAM KIF21A GPT GAREM2 VASP RASAL1	8.55e-06	192	168	7	f18da8db573e584c8b90df0814afcf020360108e
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	DNAJB11 DUSP1 BAG3 ADGRB3 HNRNPC CRY1 ATP13A3	8.55e-06	192	168	7	6bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC1 MAP2 ITGAX CRY1 SYNJ2 ATP13A3 PMM2	8.55e-06	192	168	7	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	DNAJB11 DUSP1 BAG3 CHD1 HNRNPC CRY1 ATP13A3	8.84e-06	193	168	7	dbf0fe496254320c894568c31e5f9ce63707d1b5
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL7A1 MXRA5 NRCAM NTRK3 OBSCN EBF2 MOCS1	9.14e-06	194	168	7	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37\|World / Primary Cells by Cluster	CHL1 NRCAM MAP2 NTRK3 BCL11B AK5 AGAP1	1.01e-05	197	168	7	00d756bc0231e1b3b88430214338c1059cb11106
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 NRCAM MAP2 KIF21A RET CNGB1 MAPK8IP2	1.01e-05	197	168	7	27c044833e471a312a572e0b1c83e4bc8a36e896
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCA2 TPRN USP31 SYNJ2 AK5 USP54 AGAP1	1.01e-05	197	168	7	82b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 NRCAM MAP2 KIF21A RET CNGB1 MAPK8IP2	1.04e-05	198	168	7	800ade4261695f2efd869d2b1243571de963c431
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 RAPH1 MYCBP2 BCL6 PTPRS DTX4 RNF145	1.08e-05	199	168	7	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CHL1 RAPH1 MYCBP2 BCL6 PTPRS DTX4 RNF145	1.08e-05	199	168	7	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	Frontal_cortex-Neuronal\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CHL1 USP34 HCN1 FBXO41 SYN1 PPME1 MAPK8IP2	1.08e-05	199	168	7	f88039d862f3bfa01dc39d2de4f3f548dc5a0e61
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26\|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type.	CHL1 OBSCN MAST4 SLIT1 FBXO41 MAPK8IP2 PDZD4	1.11e-05	200	168	7	61d7dd0a78942b069c3f5e75044368dc00e6e8e6
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 COL7A1 OBSCN ITGB4 USP31 DMRT3 TRPV4	1.11e-05	200	168	7	8827653738a931e4a4545e0c7d75be12bed40740
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	CHL1 OBSCN MAST4 SLIT1 FBXO41 MAPK8IP2 PDZD4	1.11e-05	200	168	7	5c7263c862093ad9dbc81d06b16b6f74e8a6b634
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTR2C EXPH5 HCN1 DMRT3 MAPK8IP2	1.39e-05	81	168	5	1a22222f2b4ab30f7aa31820029c267a0f2190ec
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPEG NTRK3 EBF2 PDLIM3 CDC25A PCDH18	3.04e-05	158	168	6	84c0a215dabf697ada036c2b9592d0c61b5077de
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 OBSCN ITGAX LMAN1L PTPRS NUP210	3.27e-05	160	168	6	237430af14830b38e58da8a4224036e5c6b71c5b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RAPH1 NTRK3 ADGRB3 TMEM132C AK5 ARHGAP19	3.38e-05	161	168	6	1b805f77790aeb8a71b08bfac2fe2eed7343258f
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	USP34 RASA1 SPEG BCL11B PCNX1 ATM	3.50e-05	162	168	6	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	Influenza_Severe-CD4+_CTL\|Influenza_Severe / Disease group and Cell class	CRY1 CFAP20DC BCL11B GAREM2 ABCG8 AGAP1	3.75e-05	164	168	6	9ffd40ae1f39290840bea79fa4e73cb7e009f310
ToppCell	Adult-Mesenchymal-myofibroblast_cell\|Adult / Lineage, Cell type, age group and donor	NRCAM NTRK3 TMEM132C PDLIM3 SYNJ2 PLEKHH2	4.15e-05	167	168	6	d584a8548a5317bd9686b3be8246ae6ed568796b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABCC1 EBF2 BCL11B SLIT1 PCNX1 MAPK8IP2	4.15e-05	167	168	6	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 COL7A1 MXRA5 DYNC2H1 PLEKHH2 PCDH18	4.44e-05	169	168	6	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	Basal_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	COL7A1 MXRA5 SOWAHC ITGB4 PTPRS TRPV4	4.58e-05	170	168	6	776d4224a682b6c648041827efd69794f88906f0
ToppCell	facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 RAPH1 ITGB4 BST1 TRPV4 CDC25A	4.58e-05	170	168	6	8e1f757ed62218c0fb6525f49d142dd2cd29acf9
ToppCell	facs-Lung-nan-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 RAPH1 ITGB4 BST1 TRPV4 CDC25A	4.58e-05	170	168	6	67d7e1da3ebd2d14cb2e67799e94d655027ed5c4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RAPH1 NTRK3 ADGRB3 TMEM132C AK5 ARHGAP19	4.89e-05	172	168	6	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RAPH1 NTRK3 ADGRB3 TMEM132C AK5 ARHGAP19	4.89e-05	172	168	6	553701349444eb366df3c11f54bb093434f153c6
ToppCell	Adult-Epithelial-basal_cell-D231\|Adult / Lineage, Cell type, age group and donor	CHL1 COL7A1 HTR2C ABCA12 CA10 ITGB4	5.22e-05	174	168	6	a4f98afe7d1cc2617f6f7bc8092c41df57474b30
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTR4 SYN3 EXPH5 CA10 NWD2 CNGB1	5.56e-05	176	168	6	07abf29d681abdd6c7cc87f9eaf9377e92ce212c
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTR4 SYN3 NTRK3 CA10 NWD2 CNGB1	5.56e-05	176	168	6	c7be4eaa5eb76ad9389fb9d15ad0934e88d267d1
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTR2C EXPH5 CA10 RGS12 NWD2 SLIT1	5.56e-05	176	168	6	de746cdf2c777eec88cb03863e128e97ad6e8fb0
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CHL1 ACACA MAST4 RNF145 AGAP1 FAM149A	5.56e-05	176	168	6	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VLDLR VEPH1 RRN3 SYN1 DSEL ARHGAP19	5.74e-05	177	168	6	164ffbbf798defa3728197deb1a14b661490e525
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTR4 SYN3 NTRK3 CA10 NWD2 CNGB1	5.74e-05	177	168	6	8b003ed7887479c3a010ef37dd981b748256bda7
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTR4 SYN3 EXPH5 CA10 NWD2 CNGB1	5.92e-05	178	168	6	5d6297f34e104bacefb25c4e2338b50fe13dd19a
ToppCell	wk_15-18-Epithelial-PNS-KCNIP4+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CHL1 RET C1orf232 NWD2 OGDHL CNGB1	6.11e-05	179	168	6	e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EXPH5 CA10 RGS12 NWD2 AK5 SLIT1	6.49e-05	181	168	6	13270b6ba6a9c8e5681c6f40000c643ce1d9344a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EXPH5 CA10 RGS12 NWD2 AK5 SLIT1	6.49e-05	181	168	6	3e3c903b522dced6bec5dc447cc3f8bf9a9749e3
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 NRCAM RAPH1 DUSP1 VEPH1 TRPV4	6.49e-05	181	168	6	b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	CHL1 MAST4 USP54 RNF145 AGAP1 FAM149A	6.49e-05	181	168	6	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA2 MAP2 KIF21A RET CNGB1 MAPK8IP2	6.69e-05	182	168	6	be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VEPH1 FER1L6 USP54 RNF145 AGAP1 FAM149A	6.69e-05	182	168	6	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYN3 CA10 NWD2 SYNJ2 AK5 SLIT1	6.69e-05	182	168	6	35b2a5625323bf0917214d3b82fafc4a8f5e75ff
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL20A1 GRIK1 CA10 TMEM132C PLEKHH2 AGAP1	6.69e-05	182	168	6	3cc61f5f7ad4a81eba3daf65e122880b5af3adc0
ToppCell	NS-moderate-d_16-33-Lymphoid-NK\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	COL7A1 NRCAM TMEM158 NTRK3 PDLIM3 PCDH18	6.69e-05	182	168	6	fb503f8ecd013f1f2161a5841572b57cfcddb6fa
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL20A1 GRIK1 CA10 TMEM132C PLEKHH2 AGAP1	6.69e-05	182	168	6	5d909e4b5f662905bf1be9c686bbddc3e87d2be9
ToppCell	Basal\|World / shred by cell class for mouse tongue	COL7A1 ITGB4 BCL11B PTPRS SLIT1 TRPV4	6.90e-05	183	168	6	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	Pericytes-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	NRCAM TMEM158 NTRK3 GAREM2 SLIT1 PCDH18	6.90e-05	183	168	6	4617b18da8d699a44e4c47980197b1e7eb951470
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ABCC1 TM9SF4 MED24 YEATS2 ATP13A3 FOXK1	6.90e-05	183	168	6	310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ABCC1 TM9SF4 MED24 YEATS2 ATP13A3 FOXK1	6.90e-05	183	168	6	fef51dcf180e6d4e136362c7e140ec5ef372e6d0
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3\|TCGA-Lung / Sample_Type by Project: Shred V9	ABCC1 COL7A1 NRCAM TMEM158 YEATS2 PTPRS	7.11e-05	184	168	6	ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYN3 NTRK3 CA10 RGS12 NWD2 ECHDC2	7.11e-05	184	168	6	30fddbc9696476d4d7f08e53f84ea994a4ed873a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYN3 NTRK3 CA10 RGS12 NWD2 ECHDC2	7.11e-05	184	168	6	96926efa220f03d0787322c9519bb9e8f64f74d0
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL20A1 GRIK1 CA10 TMEM132C PLEKHH2 AGAP1	7.33e-05	185	168	6	efc5d564f8793c751ba640aef60f761e4b081d3f
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	ACACA MAST4 USP54 RNF145 AGAP1 FAM149A	7.33e-05	185	168	6	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HTR2C ITGAX BST1 SYN1 ATP13A3 AGAP1	7.33e-05	185	168	6	4bee178ede12f56ba5f5bec44a03dc2a62c50137
ToppCell	droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	A3GALT2 ITGAX DTX4 RAD54B AGAP1 ARHGAP19	7.33e-05	185	168	6	b4af9ae4c358b48357cb135b740266e1652d886a
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 SPEG NTRK3 ITIH4 TMEM132C PDLIM3	7.33e-05	185	168	6	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL20A1 GRIK1 CA10 TMEM132C PLEKHH2 AGAP1	7.33e-05	185	168	6	fba2dc46cd98ab9c78e788959c2121aa10d148b2
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 SPEG TMEM158 NTRK3 ITIH4 PDLIM3	7.55e-05	186	168	6	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CA10 NWD2 SYNJ2 AK5 SLIT1 RASAL1	7.55e-05	186	168	6	84ba666237c18189d7e7556bd92dd953af733c00
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP2 KIF21A RET SLIT1 CNGB1 MAPK8IP2	7.77e-05	187	168	6	a748b3a59e398e0da019db3f16d38adb1960c29f
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NRCAM NTRK3 OBSCN EBF2 MOCS1 AGAP1	7.77e-05	187	168	6	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	15-Distal-Mesenchymal-Pericyte\|Distal / Age, Tissue, Lineage and Cell class	SYN3 MAP2 NTRK3 EBF2 PCDH18 MOCS1	8.00e-05	188	168	6	4963382e54aac06bf5047c7d725393db70667ee7
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NRCAM NTRK3 OBSCN EBF2 MOCS1 AGAP1	8.00e-05	188	168	6	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHL1 COL20A1 HCN1 ADGRB3 ITGB4 ARHGAP19	8.00e-05	188	168	6	502045a39ffb1e92bd9499848368e8fa971edb88
ToppCell	Pericytes-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	SPEG NTRK3 EBF2 PDLIM3 SLIT1 PCDH18	8.00e-05	188	168	6	14c1c88a944c66f2eaac1ce7526815dcce1f5147
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 SPEG NTRK3 TMEM132C PDLIM3 PCDH18	8.24e-05	189	168	6	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 NRCAM RAPH1 DUSP1 VEPH1 TRPV4	8.24e-05	189	168	6	c9565e962a13a7713056ec3dbb1b67d24f9889c7
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 NRCAM ADGRB3 TMEM132C PTPRS PLEKHH2	8.24e-05	189	168	6	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 EXPH5 KIF21A BCL6 RGS12 MAST4	8.48e-05	190	168	6	1cf023e3c6924d6a06f353d4b62444b6f2fee8a7
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; HL60; HT_HG-U133A	ABCA2 MYCBP2 DUSP1 RET UBOX5 LIG3 SYNJ2 SMARCD1 PMM2 SOS2	1.37e-06	192	164	10	1332_UP
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A	USP34 WNK1 UBOX5 ITGB4 RGS12 SYNJ2 CDC25A MOCS1 RASAL1 SOS2	1.73e-06	197	164	10	3319_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; HL60; HG-U133A	USP34 ACACA DYNC2H1 ATG13 NTRK3 ADAMTS13 RET UBOX5 RGS12 ECHDC2	1.81e-06	198	164	10	1391_UP
Drug	topiramate; Up 200; 3uM; MCF7; HT_HG-U133A_EA	VLDLR ABCA2 WNK1 RGS12 FANCC LIG3 MAST4 DIAPH1 ABCC2 SOS2	1.81e-06	198	164	10	915_UP
Drug	Chlorpyrifos	CDKN1B VLDLR HTR2C ACACA NRCAM MAP2 MYCBP2 DUSP1 NTRK3 GPT GRIN2A RET ITGAX UBOX5 BST1 SLIT1 USP7 SMARCD1 ATM PCDH18 ABCG8	5.87e-06	960	164	21	ctd:D004390
Drug	Pilocarpine	CDKN1B ABCC1 IMPA1 HTR2C HCN1 NTRK3 GRIK1 GRIN2A RET ITGB4 ABCC2	7.37e-06	285	164	11	ctd:D010862
Drug	2f1b	DNAJB11 COL7A1 PSMD4 GRIK1 ITGB4 ITIH4	8.84e-06	67	164	6	CID011963508
Drug	Yohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	USP34 ABCA2 RET RGS12 SNX13 LIG3 BCL11B FAM149A SOS2	1.19e-05	194	164	9	4082_UP
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A	USP34 ZSCAN5A WNK1 UBOX5 ITGB4 FANCC NUP210 ATM HTT	1.19e-05	194	164	9	4284_DN
Drug	Sulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A	USP34 WNK1 ITGB4 SNX13 PCNX1 ATP13A3 DDX43 ATM SOS2	1.24e-05	195	164	9	6799_DN
Drug	Niacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A	ITCH DYNC2H1 WNK1 RGS12 PHKB LIG3 DDX43 ATM MOCS1	1.30e-05	196	164	9	5301_UP
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; HL60; HG-U133A	ITCH ACACA TM9SF4 UPF1 RET UBOX5 LDAH DIAPH1 NPAT	1.30e-05	196	164	9	1775_DN
Drug	Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A	VLDLR ABCA2 UBOX5 SNX13 LIG3 SMARCD1 MOCS1 MAPK8IP2 SOS2	1.30e-05	196	164	9	4972_DN
Drug	Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A	USP34 ABCA2 EXPH5 SOWAHC UBOX5 MAST4 PTPRS PCNX1 RASAL1	1.35e-05	197	164	9	6265_UP
Drug	Androsterone [53-41-8]; Up 200; 13.8uM; PC3; HT_HG-U133A	MAP2 SPEG BCL6 UBOX5 ITGB4 RRN3 NUP210 SCN10A PCNX1	1.35e-05	197	164	9	4635_UP
Drug	Atracurium besylate [64228-81-5]; Up 200; 3.2uM; MCF7; HT_HG-U133A	ABCA2 ABCA12 SOWAHC UBOX5 LDAH SMARCD1 ATM CDC25A MOCS1	1.35e-05	197	164	9	1702_UP
Drug	Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A	USP34 SYN3 SPEG RGS12 PTPRS AK5 RAD54B NPAT SOS2	1.41e-05	198	164	9	2636_UP
Drug	Cefaclor [70356-03-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A	EXPH5 WNK1 UBOX5 RGS12 LIG3 SYNJ2 ALOX12 MOCS1 MAPK8IP2	1.41e-05	198	164	9	4967_DN
Drug	Decamethonium bromide [541-22-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ITGB4 RGS12 CRY1 BCL11B SYNJ2 RRN3 PCNX1 CDC25A SOS2	1.41e-05	198	164	9	7353_UP
Drug	Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ABCA2 SOWAHC RGS12 MAST4 RAD54B USP7 PCNX1 ATP13A3 ATM	1.41e-05	198	164	9	6838_DN
Drug	Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A	WNK1 UBOX5 ITGB4 RUSC2 FANCC SYNJ2 RAD54B PCNX1 CDC25A	1.41e-05	198	164	9	4592_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	MYCBP2 DYNC2H1 SOWAHC LIG3 DTX4 NUP210 PCNX1 ATM ARHGAP19	1.41e-05	198	164	9	1650_DN
Drug	Cefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	VLDLR SRI SOWAHC CRY1 DIAPH1 SMARCD1 PCNX1 CDC25A SOS2	1.46e-05	199	164	9	4390_DN
Drug	Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	DYNC2H1 EXPH5 PTCD2 SMARCD1 ATP13A3 CDC25A ECHDC2 RASAL1 SOS2	1.46e-05	199	164	9	7025_DN
Drug	Amiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; PC3; HT_HG-U133A	COL7A1 UBOX5 LIG3 SYNJ2 PTPRS BST1 TSKS ALOX12 MOCS1	1.46e-05	199	164	9	4000_DN
Drug	Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; PC3; HT_HG-U133A	SYN3 DUSP1 NTRK3 RET SNX13 PDLIM3 TRPV4 TSKS SOS2	1.52e-05	200	164	9	3779_UP
Drug	hydroxyrubicin	ABCC1 BCL6 TIA1 ABCC2	2.07e-05	23	164	4	CID000072398
Drug	aniracetam	SPEG GRIK1 GRIN2A CRY1 PTPRS BST1 HERC2	4.45e-05	130	164	7	CID000002196
Drug	H-Ni	ABCC1 GRIK1 RET HTT	4.64e-05	28	164	4	CID000445665
Drug	Sulfinpyrazone	ABCC1 ABCC2	5.16e-05	2	164	2	DB01138
Drug	glutathione-BPDE conjugate	ABCC1 ABCC2	5.16e-05	2	164	2	ctd:C113118
Drug	2-AOPA	GRIK1 RET	5.16e-05	2	164	2	CID003025834
Drug	robinetin	ABCC1 ABCC2	5.16e-05	2	164	2	ctd:C040014
Drug	Fluo-3	ABCC1 ABCC2	5.16e-05	2	164	2	ctd:C059715
Drug	Thimerosal	USP34 HTR2C ATG13 DUSP1 NTRK3 BAG3 UPF1 SNX21 WNK1 CA10 RUSC2 PHKB SEPSECS GAREM2 PCNX1 ATP13A3 ATM ECHDC2 GFM1 VASP FAM149A NPAT	5.20e-05	1199	164	22	ctd:D013849
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	MAP2 RET BCL6 WNK1 PCNX1 ATM ABCC2 TSKS	6.30e-05	186	164	8	4463_UP
Drug	Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A	UPF1 OCRL RET RGS12 SNX13 PCNX1 ATM MOCS1	6.79e-05	188	164	8	3325_DN
Drug	testosterone enanthate	USP34 MXRA5 ZNF148 DUSP1 WNK1 HNRNPC FANCC TYK2 USP31 YEATS2 PTCD2 VASP FAM149A SOS2	7.54e-05	575	164	14	ctd:C004648
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A	USP34 WNK1 BCL11B SYNJ2 AK5 PCNX1 ATM MOCS1	7.86e-05	192	164	8	3729_DN
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A	USP34 SPEG FBXO41 PCNX1 ATM CDC25A MAPK8IP2 SOS2	7.86e-05	192	164	8	3382_DN
Drug	AG-028671 [847803-03-6]; Up 200; 10uM; MCF7; HT_HG-U133A	USP34 VLDLR ITCH ABCA12 DUSP1 UBOX5 ITGB4 ATP13A3	8.15e-05	193	164	8	6587_UP
Drug	Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; HL60; HT_HG-U133A	DYNC2H1 ATG13 TMEM158 UBOX5 RUSC2 SYNJ2 SMARCD1 PCNX1	8.15e-05	193	164	8	1873_DN
Drug	Omeprazole [73590-58-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A	EXPH5 ATG13 UBOX5 MAST4 SYNJ2 PCNX1 RASAL1 SOS2	8.15e-05	193	164	8	2828_DN
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	USP34 ATG13 TMEM158 POMT1 RET ITGAX UBOX5 DTX4	8.45e-05	194	164	8	1185_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; HL60; HG-U133A	ABCA2 RASA1 UBOX5 PHKB NUP210 ATM CDC25A NPAT	8.45e-05	194	164	8	1377_DN
Drug	Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A	USP34 WNK1 MAST4 DIAPH1 SMARCD1 CDC25A ECHDC2 MOCS1	8.45e-05	194	164	8	6811_DN
Drug	Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A	EXPH5 SRI UBOX5 RGS12 SNX13 PCNX1 ATM SOS2	8.76e-05	195	164	8	3330_DN
Drug	Nitrendipine [39562-70-4]; Up 200; 11uM; MCF7; HT_HG-U133A	RET BCL6 RUSC2 LIG3 RRN3 PCNX1 ATP13A3 SOS2	8.76e-05	195	164	8	5405_UP
Drug	Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A	EXPH5 OCRL BCL6 UBOX5 RGS12 PCNX1 RASAL1 SOS2	8.76e-05	195	164	8	4345_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	ATG13 RET WNK1 ITGB4 NUP210 SMARCD1 DDX43 NPAT	8.76e-05	195	164	8	1639_DN
Drug	Glycopyrrolate [596-51-0]; Up 200; 10uM; MCF7; HT_HG-U133A	WNK1 UBOX5 ITGB4 RGS12 LIG3 MAST4 FBXO41 ATM	8.76e-05	195	164	8	3427_UP
Drug	Flufenamic acid [530-78-9]; Down 200; 14.2uM; HL60; HG-U133A	ABCC1 HTR4 POMT1 CRY1 LIG3 FBXO41 PCNX1 ATM	8.76e-05	195	164	8	1420_DN
Drug	Sulfadoxine [2447-57-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A	USP34 TMEM158 WNK1 UBOX5 RGS12 BCL11B ATM SOS2	9.08e-05	196	164	8	7205_UP
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A	ITCH HTR4 UPF1 OCRL SNX13 LIG3 SMARCD1 SOS2	9.08e-05	196	164	8	2005_DN
Drug	Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	USP34 ABCA2 UPF1 SYNJ2 PTPRS FBXO41 ATM MOCS1	9.08e-05	196	164	8	2329_DN
Drug	Asiaticoside [16830-15-2]; Up 200; 4.2uM; HL60; HT_HG-U133A	USP34 ABCA2 NRCAM EXPH5 ADAMTS13 RAD54B NCOA1 PCNX1	9.08e-05	196	164	8	2943_UP
Drug	Pentetic acid [67-43-6]; Up 200; 10.2uM; PC3; HT_HG-U133A	ABCA2 ADGRB3 EBF2 AK5 OGDHL PCNX1 ALOX12 SOS2	9.08e-05	196	164	8	4669_UP
Drug	Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A	HTR4 SPEG ADAMTS13 BCL6 BST1 PCNX1 MOCS1 SOS2	9.08e-05	196	164	8	2862_UP
Drug	Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A	VLDLR ABCA12 EXPH5 BCL11B USP7 CDC25A RASAL1 ARHGAP19	9.08e-05	196	164	8	7432_UP
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A	UBOX5 SNX13 MED24 LIG3 TIA1 SYNJ2 RAD54B MOCS1	9.41e-05	197	164	8	2285_DN
Drug	Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	ABCA2 HTR4 SYN3 UBOX5 RUSC2 PDLIM3 SCN10A FBXO41	9.41e-05	197	164	8	2637_UP
Drug	Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A	USP34 BCL6 WNK1 PDLIM3 PTPRS SCN10A SMARCD1 ABCC2	9.41e-05	197	164	8	3447_UP
Drug	Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A	ABCC1 COL7A1 TMEM158 PCNX1 DDX43 ATM CDC25A MOCS1	9.41e-05	197	164	8	4717_DN
Drug	Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	ABCA2 TMEM158 ADAMTS13 RGS12 SNX13 TRPV4 CDC25A MAPK8IP2	9.41e-05	197	164	8	2752_UP
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	USP34 COL7A1 ITGB4 RGS12 SYNJ2 PCNX1 ATM SOS2	9.41e-05	197	164	8	3300_DN
Drug	(+/-)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A	NRCAM MYCBP2 ATG13 RRP1 PPP1R8 NUP210 ATP13A3 AGAP1	9.41e-05	197	164	8	161_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	ABCC1 ABCA12 ITGB4 TYK2 NUP210 RAD54B USP7 PCNX1	9.74e-05	198	164	8	6976_UP
Drug	Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A	SRI SNX13 MAST4 SYNJ2 USP7 NCOA1 PCNX1 SOS2	9.74e-05	198	164	8	5246_DN
Drug	Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	ABCA2 DYNC2H1 SPEG ITGB4 LIG3 NUP210 RAD54B PTCD2	9.74e-05	198	164	8	7126_UP
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; HL60; HT_HG-U133A	CHL1 HTR4 NTRK3 GRIK1 SNX13 LIG3 PDLIM3 TRPV4	9.74e-05	198	164	8	3059_UP
Drug	Chenodiol [474-25-9]; Up 200; 10.2uM; MCF7; HT_HG-U133A	USP34 VLDLR SRI USP7 FBXO41 PCNX1 MOCS1 ARHGAP19	9.74e-05	198	164	8	7433_UP
Drug	Propidium iodide [25535-16-4]; Down 200; 6uM; HL60; HT_HG-U133A	ITGB4 SNX13 RUSC2 SCN10A USP7 PTCD2 ABCC2 SOS2	9.74e-05	198	164	8	2541_DN
Drug	tianeptine	GPT ABCC2 ABCG8	9.95e-05	13	164	3	ctd:C050504
Drug	Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A	ABCC1 ABCA2 UBOX5 RGS12 RUSC2 MAST4 USP7 SMARCD1	1.01e-04	199	164	8	6795_UP
Drug	Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A	ABCA2 SPEG OCRL WNK1 SNX13 BCL11B FBXO41 PCNX1	1.01e-04	199	164	8	5048_UP
Drug	Fenbendazole [43210-67-9]; Up 200; 13.4uM; PC3; HT_HG-U133A	COL7A1 NRCAM DUSP1 EBF2 MAST4 TSKS CNGB1 FAM149A	1.01e-04	199	164	8	3805_UP
Drug	Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; HL60; HT_HG-U133A	USP34 DYNC2H1 EXPH5 RRP1 DTX4 ATP13A3 DDX43 SOS2	1.01e-04	199	164	8	1337_DN
Drug	Pyrilamine maleate [59-33-6]; Down 200; 10uM; HL60; HG-U133A	ABCC1 UPF1 WNK1 LIG3 NUP210 DIAPH1 NCOA1 CDC25A	1.01e-04	199	164	8	1568_DN
Drug	Praziquantel [55268-74-1]; Up 200; 12.8uM; HL60; HG-U133A	USP34 BCL6 ITGAX CRY1 BST1 PCNX1 RASAL1 HTT	1.01e-04	199	164	8	1572_UP
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; HL60; HG-U133A	ZSCAN5A SNX13 TIA1 NUP210 DIAPH1 PCNX1 VASP HTT	1.01e-04	199	164	8	1588_DN
Drug	Clorgyline hydrochloride [17780-75-5]; Up 200; 13uM; PC3; HT_HG-U133A	ABCA2 NRCAM RET SNX13 BCL11B PDLIM3 AK5 FAM149A	1.04e-04	200	164	8	6659_UP
Drug	Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ATG13 ADAMTS13 WNK1 RUSC2 PDLIM3 SCN10A OGDHL SOS2	1.04e-04	200	164	8	5513_UP
Drug	Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; HL60; HG-U133A	ABCC1 ACACA HTR4 TMEM158 UPF1 RRP1 SMARCD1 HTT	1.04e-04	200	164	8	2027_DN
Drug	Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A	ABCA2 HTR4 MAP2 NTRK3 GRIK1 UBOX5 MAST4 SMARCD1	1.04e-04	200	164	8	6005_UP
Drug	Xylazine [7361-61-7]; Up 200; 18.2uM; MCF7; HT_HG-U133A	ABCA2 HTR2C SPEG CA10 RGS12 SCN10A FBXO41 SYN1	1.04e-04	200	164	8	2788_UP
Drug	Meclizine	RET NCOA1 ABCC2	1.26e-04	14	164	3	ctd:D008468
Drug	Chenodeoxycholic Acid	CDKN1B ABCC1 GPT NCOA1 ABCC2 ABCG8	1.26e-04	107	164	6	ctd:D002635
Drug	Se-methylselenocysteine	CDKN1B ABCC1 COL7A1 ITGAX CDC25A	1.32e-04	68	164	5	CID000114835
Drug	AC1NRB3N	IMPA1 DUSP1 BCL6 ITIH4	1.42e-04	37	164	4	CID005288242
Drug	digalloylresveratrol	ATM CDC25A	1.54e-04	3	164	2	ctd:C534866
Drug	S-(2,4-dinitrophenyl)glutathione	ABCC1 ABCC2	1.54e-04	3	164	2	ctd:C030190
Drug	5-carboxyfluorescein diacetate	ABCC1 ABCC2	1.54e-04	3	164	2	ctd:C084577
Drug	taxol	CDKN1B ABCC1 MAP2 HCN1 SRI RET ITGB4 SCN10A ATM ABCC2 CDC25A MAPK8IP2 HTT	2.18e-04	560	164	13	CID000004666
Drug	antibiotic G 418	ABCC1 ATM ABCC2	2.32e-04	17	164	3	ctd:C010680
Disease	Colorectal Carcinoma	CHL1 ABCC1 COL7A1 ACACA NRCAM MAP2 ABCA12 ZSCAN5A OBSCN CHD1 GRIN2A RET WNK1 LIG3 BCL11B PTPRS ABCC2 DSEL TSKS PMM2	2.06e-09	702	162	20	C0009402
Disease	Colorectal Neoplasms	ABCC1 COL7A1 NRCAM ABCA12 CHD1 GRIN2A RET ABCC2 PMM2	2.40e-05	277	162	9	C0009404
Disease	Bipolar Disorder	IMPA1 HTR2C HTR4 SYN3 MAP2 GRIK1 GRIN2A ME2 ITIH4 CRY1 ALOX12	7.03e-05	477	162	11	C0005586
Disease	Mental Depression	HTR2C HTR4 HCN1 DUSP1 GRIN2A CRY1 SYN1 HTT	8.53e-05	254	162	8	C0011570
Disease	Multiple Endocrine Neoplasia	CDKN1B RET	8.95e-05	3	162	2	C0027662
Disease	orofacial cleft, sex interaction measurement	NRCAM EXPH5 BCL11B SCN10A AGAP1	1.14e-04	86	162	5	EFO_0008343, MONDO_0000358
Disease	ocular hypertension, response to triamcinolone acetonide	GRIK1 ITGB4 TMEM132C STX10	1.53e-04	49	162	4	EFO_0006954, EFO_1001069
Disease	pheochromocytoma (implicated_via_orthology)	CDKN1B RET	1.78e-04	4	162	2	DOID:0050771 (implicated_via_orthology)
Disease	Epidermolysis Bullosa	EXPH5 ITGB4	1.78e-04	4	162	2	C0014527
Disease	Depressive disorder	HTR2C HTR4 HCN1 DUSP1 GRIN2A CRY1 SYN1 HTT	2.07e-04	289	162	8	C0011581
Disease	household income	UBOX5 MAST4 AK5 PCNX1 CDC25A STX10 HTT AGAP1	2.90e-04	304	162	8	EFO_0009695
Disease	Malignant neoplasm of breast	CDKN1B ABCC1 COL7A1 NRCAM RAPH1 DYNC2H1 OBSCN WNK1 PHKB SYNJ2 NCOA1 SMARCD1 ATM USP54 HERC2 PDZD4	2.95e-04	1074	162	16	C0006142
Disease	cyclin-dependent kinase inhibitor 1b measurement	CDKN1B ITIH4	2.96e-04	5	162	2	EFO_0020298
Disease	Epidermolysis Bullosa Simplex	EXPH5 ITGB4	2.96e-04	5	162	2	C0079298
Disease	Mood Disorders	HTR2C HTR4 MAP2 NTRK3 GRIN2A HTT	3.42e-04	168	162	6	C0525045
Disease	Polycystic Kidney Diseases	DNAJB11 PMM2	4.43e-04	6	162	2	C0022680
Disease	disease of cellular proliferation (implicated_via_orthology)	TYK2 ATM	6.18e-04	7	162	2	DOID:14566 (implicated_via_orthology)
Disease	hepatocyte growth factor activator measurement	RGS12 HTT	6.18e-04	7	162	2	EFO_0008152
Disease	laurylcarnitine measurement	ABCC1 AK5	6.18e-04	7	162	2	EFO_0021041
Disease	infertility (implicated_via_orthology)	CDKN1B ATM	6.18e-04	7	162	2	DOID:5223 (implicated_via_orthology)
Disease	MASA syndrome (implicated_via_orthology)	CHL1 NRCAM	6.18e-04	7	162	2	DOID:0060246 (implicated_via_orthology)
Disease	Breast Carcinoma	CDKN1B ABCC1 COL7A1 NRCAM DYNC2H1 SYNJ2 NCOA1 SMARCD1 ATM HERC2	8.17e-04	538	162	10	C0678222
Disease	Cholestasis of pregnancy	ABCC2 ABCG8	8.21e-04	8	162	2	C0268318
Disease	sexual dimorphism measurement	SEC16B COL7A1 ITCH SYN3 ADAMTS13 GRIN2A BCL6 SPATA31C1 HNRNPC SNX13 FANCC MED24 RRN3 AK5 SLIT1	1.19e-03	1106	162	15	EFO_0021796
Disease	Schizophrenia	CHL1 VLDLR HTR2C HTR4 SYN3 NTRK3 GRIK1 GRIN2A ME2 RGS12 SYN1 ATM ALOX12	1.22e-03	883	162	13	C0036341
Disease	neurodegenerative disease (implicated_via_orthology)	RASA1 GRIK1 BCL11B OGDHL HTT	1.26e-03	145	162	5	DOID:1289 (implicated_via_orthology)
Disease	Neoplasm of uncertain or unknown behavior of breast	CDKN1B SMARCD1 HERC2	1.49e-03	41	162	3	C0496956
Disease	Breast adenocarcinoma	CDKN1B SMARCD1 HERC2	1.49e-03	41	162	3	C0858252
Disease	hepatocellular carcinoma	VEPH1 GRIK1 HNRNPC	1.49e-03	41	162	3	EFO_0000182
Disease	autism spectrum disorder (implicated_via_orthology)	HTR2C SYN3 NRCAM CHD1 SYN1	1.55e-03	152	162	5	DOID:0060041 (implicated_via_orthology)
Disease	left ventricular systolic function measurement	BAG3 OBSCN SNX13	1.82e-03	44	162	3	EFO_0008206
Disease	Amelogenesis Imperfecta	ITGB4 FAM83H	1.91e-03	12	162	2	C0002452
Disease	Carcinoma, Neuroendocrine	CDKN1B RET	1.91e-03	12	162	2	C0206695
Disease	Hirschsprung's disease (implicated_via_orthology)	RET MED24	1.91e-03	12	162	2	DOID:10487 (implicated_via_orthology)
Disease	level of Phosphatidylinositol (16:0_18:1) in blood serum	RRN3 USP7	1.91e-03	12	162	2	OBA_2045152
Disease	Gastric Adenocarcinoma	SPEG NTRK3 ATM	1.95e-03	45	162	3	C0278701
Disease	Hereditary Motor and Sensory-Neuropathy Type II	WNK1 TRPV4	2.25e-03	13	162	2	C0270914
Disease	status epilepticus (biomarker_via_orthology)	HCN1 GRIN2A ATM ABCC2	2.28e-03	100	162	4	DOID:1824 (biomarker_via_orthology)
Disease	Generalized seizures	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0234533
Disease	Clonic Seizures	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0234535
Disease	Convulsive Seizures	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0751494
Disease	Seizures, Sensory	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0751496
Disease	Non-epileptic convulsion	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0751056
Disease	Atonic Absence Seizures	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0751123
Disease	Complex partial seizures	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0149958
Disease	Single Seizure	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0751110
Disease	Nonepileptic Seizures	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C3495874
Disease	Visual seizure	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0270824
Disease	Epileptic drop attack	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0270846
Disease	Vertiginous seizure	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0422855
Disease	Gustatory seizure	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0422854
Disease	Seizures, Somatosensory	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0422850
Disease	Olfactory seizure	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0422853
Disease	Seizures, Auditory	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0422852
Disease	Generalized Absence Seizures	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C4505436
Disease	Jacksonian Seizure	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C0022333
Disease	Epileptic Seizures	IMPA1 HCN1 GRIK1 ABCC2	2.36e-03	101	162	4	C4317109
Disease	Absence Seizures	IMPA1 HCN1 GRIK1 ABCC2	2.45e-03	102	162	4	C4316903
Disease	Convulsions	IMPA1 HCN1 GRIK1 ABCC2	2.45e-03	102	162	4	C4048158
Disease	Tonic Seizures	IMPA1 HCN1 GRIK1 ABCC2	2.45e-03	102	162	4	C0270844
Disease	cholestasis (biomarker_via_orthology)	ADAMTS13 ABCC2 ABCG8	2.49e-03	49	162	3	DOID:13580 (biomarker_via_orthology)
Disease	Agents acting on the renin-angiotensin system use measurement	CDKN1B RGS12 EBF2 PCNX1 CDC25A PCDH18 SOS2	2.60e-03	335	162	7	EFO_0009931
Disease	Seizures, Focal	IMPA1 HCN1 GRIK1 ABCC2	2.63e-03	104	162	4	C0751495
Disease	Myoclonic Seizures	IMPA1 HCN1 GRIK1 ABCC2	2.63e-03	104	162	4	C4317123
Disease	Tonic - clonic seizures	IMPA1 HCN1 GRIK1 ABCC2	2.63e-03	104	162	4	C0494475
Disease	electrocardiography	MYCBP2 HCN1 SPEG BAG3 OBSCN LIG3 MAST4 SCN10A PCNX1	2.73e-03	530	162	9	EFO_0004327
Disease	Neoplasm of uncertain or unknown behavior of bladder	FANCC ATM	3.00e-03	15	162	2	C0496930
Disease	Benign neoplasm of bladder	FANCC ATM	3.00e-03	15	162	2	C0154017
Disease	P wave duration	HCN1 SCN10A	3.00e-03	15	162	2	EFO_0005094
Disease	Carcinoma in situ of bladder	FANCC ATM	3.00e-03	15	162	2	C0154091
Disease	Carcinoma of Endocrine Gland	CDKN1B RET	3.00e-03	15	162	2	C1704374
Disease	Neuralgia, Supraorbital	HTR2C SCN10A	3.42e-03	16	162	2	C0038870
Disease	Neuralgia	HTR2C SCN10A	3.42e-03	16	162	2	C0027796
Disease	Neuralgia, Atypical	HTR2C SCN10A	3.42e-03	16	162	2	C0234247
Disease	Neuralgia, Stump	HTR2C SCN10A	3.42e-03	16	162	2	C0234249
Disease	Neuralgia, Iliohypogastric Nerve	HTR2C SCN10A	3.42e-03	16	162	2	C0423712
Disease	Neuralgia, Perineal	HTR2C SCN10A	3.42e-03	16	162	2	C0423711
Disease	Seasonal Affective Disorder	HTR2C CRY1	3.42e-03	16	162	2	C0085159
Disease	Paroxysmal Nerve Pain	HTR2C SCN10A	3.42e-03	16	162	2	C0751373
Disease	Nerve Pain	HTR2C SCN10A	3.42e-03	16	162	2	C0751372
Disease	Neuralgia, Ilioinguinal	HTR2C SCN10A	3.42e-03	16	162	2	C0751371
Disease	Neuralgia, Vidian	HTR2C SCN10A	3.42e-03	16	162	2	C0042656
Disease	succinylcarnitine measurement	ABCC1 SYN3	3.42e-03	16	162	2	EFO_0020020
Disease	ecosanoids measurement	ABCC1 ABCC2 ABCG8	3.46e-03	55	162	3	EFO_0020044
Disease	apolipoprotein B measurement	VLDLR RAPH1 MKRN2 LDAH RGS12 LMAN1L PLEKHH2 VASP ABCG8 HTT	3.75e-03	663	162	10	EFO_0004615
Disease	free cholesterol to total lipids in medium VLDL percentage	RGS12 RRN3 ABCG8	3.83e-03	57	162	3	EFO_0022284
Disease	major depressive disorder (is_marker_for)	DUSP1 SYN1	3.86e-03	17	162	2	DOID:1470 (is_marker_for)
Disease	cardiovascular disease	USP34 EBF2 BCL11B PCNX1 CDC25A PCDH18 ABCG8 SOS2	3.88e-03	457	162	8	EFO_0000319
Disease	psoriasis	SPATA31C1 HNRNPC RUSC2 TYK2 SLIT1 RNF145	4.08e-03	273	162	6	EFO_0000676
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	SEC16B NRCAM HNRNPC RGS12 SNX13 ABCG8	4.31e-03	276	162	6	EFO_0004612, EFO_0020943
Disease	acute pancreatitis	HTR4 ABCG8	4.33e-03	18	162	2	EFO_1000652
Disease	drug-Induced dyskinesia, response to levodopa	TMEM158 TMEM132C	4.33e-03	18	162	2	EFO_0010747, EFO_1000904
Disease	Carcinoma of bladder	FANCC ATM	4.33e-03	18	162	2	C0699885
Disease	colorectal cancer (is_implicated_in)	NTRK3 GRIN2A RAD54B ATM	4.52e-03	121	162	4	DOID:9256 (is_implicated_in)
Disease	Noonan-Like Syndrome With Loose Anagen Hair	RASA1 SOS2	4.82e-03	19	162	2	C3501846
Disease	Noonan syndrome-like disorder with loose anagen hair	RASA1 SOS2	4.82e-03	19	162	2	C1843181
Disease	Cardio-facio-cutaneous syndrome	RASA1 SOS2	4.82e-03	19	162	2	C1275081
Disease	Costello syndrome (disorder)	RASA1 SOS2	4.82e-03	19	162	2	C0587248
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	CDKN1B ATM	4.82e-03	19	162	2	C1333991
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	CDKN1B ATM	4.82e-03	19	162	2	C2936783

Protein segments in the cluster

Peptide	Gene	Start	Entry
LRMAGDPVANVRFNV	PPP2R1A	526	P30153
NFSIDPARTLMVGDR	BARGIN	606	Q6ZT62
AQAMGQRPITFLRQV	GPT	71	P24298
TIRDGQVSFEMLPRQ	CATSPERG	376	Q6ZRH7
VNSFADNTRRFMPLS	BST1	116	Q10588
SSQAFRQEMLQRRPP	B4GALT3	361	O60512
FANSENPELRATMRG	CIBAR2	56	Q6ZTR7
INLAFMSTRQFERTP	ATG13	191	O75143
FVLMATPNLSRRNNN	AGAP1	831	Q9UPQ3
QTLDRFRDIPNTSSM	ADGRB3	1446	O60242
GIVRQFPFSSALQRM	ATP13A3	621	Q9H7F0
RSNRMNTPQGSFSTI	ABCA12	711	Q86UK0
NRNRTLMPNTTLTYD	GRIK1	66	P39086
PRGTMQAINNERKAS	HTR2C	296	P28335
AGNPRDMRRFQVVLS	EBF2	201	Q9HAK2
RGNIPTLNRMSFSSN	ACACA	1191	Q13085
AQMRLPRTFSQAQRD	ABCG8	171	Q9H221
QNRTARALGNLAMEP	ARMC5	171	Q96C12
ISPLDASGQRFRETM	ERVV-2	516	B6SEH9
SNQVFLGRVSVPRTM	ANKRD50	1371	Q9ULJ7
TFNPMSQLARRVQGV	C1orf232	46	A0A0U1RR37
MSNVRVSNGSPSLER	CDKN1B	1	P46527
VSNGSPSLERMDARQ	CDKN1B	6	P46527
TAQNLSIFLGSFRMP	DIAPH1	856	O60610
QSMNQFRQDTGTLRP	DTX4	61	Q9Y2E6
PRMRNCAKQISFNGS	CHD1	1071	O14646
MSQQCARTDGQPLRS	ADAMTS13	446	Q76LX8
SRMNFRPGVLSSRQL	ITIH4	656	Q14624
LRSNRNAMQPSTNAE	NWD2	181	Q9ULI1
DRNLSGMAERKTQPS	MKRN2	111	Q9H000
MRRSAAPSQLQGNSF	RAD54B	1	Q9Y620
VARTMDPNTLFRSNS	RASAL1	331	O95294
VKRSPLRQETNMANF	RAPH1	51	Q70E73
RRPGSFVLSFLSQMN	RASA1	211	P20936
MNFVRAVISQFQRPS	ITGAX	171	P20702
LNSMQNFLRGRPKTF	PPME1	191	Q9Y570
FRAMQRGNSPLLVVN	PCDH18	66	Q9HCL0
IRSMQSSPRFAGSQR	NPAT	96	Q14207
SIRMQGASRLPNSTI	NUP210	326	Q8TEM1
SAMTPQNLNRFRANS	KRT84	21	Q9NSB2
PRSMNSRVFIGNLNT	HNRNPC	11	P07910
NILRFSGQRNSGMVP	CHL1	866	O00533
NADGSQLPLFRMNIS	NTRK3	191	Q16288
MDNSFQRLPQSERVS	NRCAM	181	Q92823
QNRVLSAMPDGTERS	FAM149A	686	A5PLN7
RRSFLRNVMPENSNF	AK5	76	Q9Y6K8
VSGNEVNISPGRRFM	HERC2	916	O95714
QRLRMSLNSGLTPSD	LMAN1L	196	Q9HAT1
LMNRPSARNALGNVF	ECHDC2	46	Q86YB7
ESMRPVAQSVGRAFL	MAPK8IP2	791	Q13387
MSLVNFEPAARRASN	PCNX1	891	Q96RV3
NQIGFTTDPRMARSS	OGDHL	431	Q9ULD0
PLRRAMAGNSNLNRT	PDZD4	491	Q76G19
ILGPQSRDIFRMSNS	VEPH1	341	Q14D04
TENMTAFRLSNRGPL	EXPH5	1326	Q8NEV8
FINRSQRTGSGRLMP	MFSD2B	101	A6NFX1
LFSGSLRMNLDPFNN	ABCC2	1386	Q92887
QFLNGANPMLLRRST	ALOX12	231	P18054
GQRRALSVQASLMTP	LIG3	466	P49916
QIDTTLRRSQMSPQG	ITGB4	91	P16144
SPMFIINRNTGEIRT	DSG1	206	Q02413
PRSANPAMQLDRFIQ	PEF1	231	Q9UBV8
RHLSQPQLSSDRMFG	PLEKHH2	456	Q8IVE3
PQLSSDRMFGTNRNA	PLEKHH2	461	Q8IVE3
FNRNSTILTRPGMEI	IL20RB	131	Q6UXL0
HVQGLRPRMSFSSQV	MOCS1	406	Q9NZB8
GQPMNLRAEARSETS	PTPRS	526	Q13332
MRRINFQTPDSGLRS	PTPRS	1341	Q13332
PVQRIEQCTRGSLFM	CBLL1	151	Q75N03
QRPQEQATMRKFSLG	OBSCN	7166	Q5VST9
PAQVDVSRNLSFMAR	POMT1	531	Q9Y6A1
SFQQIMSFSPQDLRR	ITCH	561	Q96J02
EGPLNNLRESLMQFS	UPF1	911	Q92900
FGLPANIARSSQRMI	DYNC2H1	3996	Q8NCM8
MRRQKRPSSGTIFND	ATM	1916	Q13315
VMLSLSNFTQRAPVA	HTT	3036	P42858
PQRVTLFRQMSSGAI	HCN1	836	O60741
NFLGDSNPFNLLRMT	BCL11B	281	Q9C0K0
RRSIISPNFSFMGQL	DUSP1	291	P28562
ARGPRSSSAAFQLQM	COL20A1	1016	Q9P218
MLRNTLARSQSSPFL	DMRT3	371	Q9NQL9
MQRSDIFRVAIAGAP	DPP8	766	Q6V1X1
VANFERPRMNANSLL	CRY1	231	Q16526
LNGFNTQRRMAPERV	FANCC	166	Q00597
FLMRQPSVTIGRNSS	FOXK1	116	P85037
RQDNFSLPSGMALLQ	ABCA2	541	Q9BZC7
TMSQLRDNFTGALRP	A3GALT2	51	U3KPV4
IQMLQRAGASSESRP	HTR4	226	Q13639
LNNIVNRSMTGSPRS	BCL6	446	P41182
RTTQLGPGRFQMTQE	DNAJB11	176	Q9UBS4
QPTRFSNRCLQMIGR	FBXO41	726	Q8TF61
VRMRSQALGQSAPSL	MAST4	196	O15021
NPRTNKGMAFTLQER	ME2	31	P23368
RRLAPGMDSVQTFFA	COL7A1	1201	Q02388
MARRSQSSSQGDNPL	FAM83H	1	Q6ZRV2
QPGMQRFRTEAAAAA	BAG3	116	O95817
SSNPFLNRMLNRDTI	CA10	191	Q9NS85
TFINKLDRMGSNPAR	GFM1	171	Q96RP9
MRNGDFLPTRLQAQQ	PSMD4	16	P55036
SLPEQRSQMKGAFDR	DSEL	966	Q8IZU8
ATPGRLNDLQMSNFV	DDX43	371	Q9NXZ2
VPLKDQRNVSMRFSN	PHKB	471	Q93100
QRNVSMRFSNQGPLE	PHKB	476	Q93100
LFTQRQNSAPARMLS	CDC25A	171	P30304
QNSAPARMLSSNERD	CDC25A	176	P30304
MAAAFRPSNRVLLQA	PTCD2	6	Q8WV60
MGRRNNTNVPDFILT	OR8H1	1	Q8NGG4
MSFFERTPSGNLVNR	ABCC1	1061	P33527
EFRNGMLNVSPIGRS	PMM2	121	O15305
DFLGTLEMNLNSFPR	FER1L6	1706	Q2WGJ9
RFSTRSPLELQMQEG	GAREM2	236	Q75VX8
MFQLVAQTVGSRREP	RUSC2	1416	Q8N2Y8
RNNRQMLPVIRSTAG	RRN3	531	Q9NYV6
RRLSDSNFMANLPNG	SYN1	6	P17600
RRLSDSSFMANLPNG	SYN3	6	O14994
DTFVNPLRNSMRNVS	SNX13	701	Q9Y5W8
SMPSFTARLTRGQLQ	UBOX5	441	O94941
RRFFENLNPMGSASE	SOS2	986	Q07890
DPSVGRFRNMVQTAV	PPP1R8	216	Q12972
TQREFMLSFARDPQG	SMARCD1	436	Q96GM5
TRQMLQNGTSSRDPT	TAS2R3	211	Q9NYW6
PRNRSSSLFNEVVQM	TMEM132C	371	Q8N3T6
ENVSPRFQKGTLRMN	SYNJ2	371	O15056
GPFDLMSRRVIAANN	IMPA1	241	P29218
ISLAQFMSPRRQVTS	NCOA1	481	Q15788
QMIRQLAGPLFSENT	MED24	641	O75448
RPSENMLIRVNNDGT	MYCBP2	2396	O75592
QPRQSGSFRVLQGMV	PDLIM3	246	Q53GG5
RLFEMASRQSTPSQN	RRP1	306	P56182
MTQQPLRGVTSLRFN	WDR45	1	Q9Y484
ARQNLRDLVMGSSPQ	SOWAHC	201	Q53LP3
RQRDTTMSPLLFQAQ	SPATA31C1	316	P0DKV0
MARQTPSDRQRAIQF	OCRL	876	Q01968
PLSGRRNNMKISSET	CFAP20DC	146	Q6ZVT6
RAQGAEISEMNSPSR	CNGB1	86	Q14028
SPERAQGMATLVFSR	TEX13D	541	A0A0J9YY54
GIMLQDPRSQLRQFS	ZC3H6	846	P61129
IIPMFTQNIREGFRS	TMEM68	231	Q96MH6
PDDRRFFGLVTMQTN	RGS12	306	O14924
RGDRIVNTPFQVLMN	TM9SF4	81	Q92544
PFVGENDRTTLMNIR	SPEG	1796	Q15772
TDASRTGAQQKMRIP	KIF21A	871	Q7Z4S6
MEFPIGSLETNNFRR	SCN10A	1	Q9Y5Y9
FLPNGMEQRRTTAST	TMEM158	251	Q8WZ71
MVSPTAVAFLERNNR	STX10	106	O60499
NLQRQFRGPMAAISF	SNX21	181	Q969T3
VSSQRASSVNQMRPG	ZSCAN5A	161	Q9BUG6
RNNEIGNPVSSLRSM	USF3	1756	Q68DE3
RQFQNSRRGPDLSMN	TSKS	426	Q9UJT2
ENRNLLFSGSPAVTM	ARHGAP19	461	Q14CB8
TLFQLMSGRIPQAAT	SEC16B	501	Q96JE7
GRSAIEQRSMSINLP	MAP2	691	P11137
GARRPSLDSMENQVS	RET	691	P07949
DSMISISRFPRQGDL	ZNF234	116	Q14588
ASLRANSRNSFMVIP	TPRN	321	Q4KMQ1
MNRESFAAGERLVSP	SEPSECS	1	Q9HD40
AKLQMRSNSPSRFSG	USP31	871	Q70CQ4
INSFRSGMNSPLRTT	ZNF148	656	Q9UQR1
LIPSNSFRQMFRSTR	USP34	2691	Q70CQ2
AFSELRRAQMTEGPN	WNK1	1306	Q9H4A3
QMVQAVRRDSGLQPF	nan	76	Q6AWC8
LTANQLESIRSGMFR	SLIT1	596	O75093
EPLSMNRFTTALIGQ	RNF145	116	Q96MT1
QARSNGTKRPAMLDN	USP7	626	Q93009
IAERTGNMREFINSP	TRPV4	216	Q9HBA0
TMGFRLSPQAVNSIA	SRI	131	P30626
RQTFSPFGQIMEIRV	TIA1	231	P31483
SNNMEQRPSRNTGRD	YEATS2	166	Q9ULM3
FLRDFQPGRLSQQMV	TYK2	241	P29597
RLPGTSRSVQQFLAM	USP54	1496	Q70EL1
NPTANSFRVVGRKMQ	VASP	41	P50552
MNGFDRRPLVTADIQ	VLDLR	586	P98155
RRGLQVMNLENEFSP	LDAH	211	Q9H6V9
STGALMTPNTRIQRF	MXRA5	1891	Q9NR99
ENFRKGDSTLPMNRN	GRIN2A	1156	Q12879